COA Available
Performance In Stock Research Use Only
AOD-9604
10mg · Lyophilized Powder · Purity ≥99%
AOD9604 is a synthetic peptide corresponding to amino acids 177–191 of the C-terminus of human growth hormone (hGH), identified as the region responsible for hGH's lipolytic activity. Unlike full-length hGH, AOD9604 does not significantly modulate IGF-1 levels or glucose metabolism in preclinical studies, making it a selective tool for adipose biology research.
$75.99 CAD
Purchase Options
Subscriptions can be managed from your customer account. Prices in CAD.
Research Overview
Research interest in AOD9604 centres on its ability to recapitulate the lipolytic properties of native hGH as an isolated peptide fragment, enabling investigators to study adipose lipid mobilisation mechanisms and beta-3 adrenergic receptor signalling without the pleiotropic metabolic effects associated with full-length growth hormone. Originally evaluated as an anti-obesity drug candidate in formal clinical development, its well-characterised preclinical profile supports its continued use as a reference compound in lipid metabolism research. BME Health supplies AOD9604 at research-grade purity with full COA. Supplied exclusively for laboratory and research use.
Preclinical studies have used AOD9604 to characterise lipolysis mechanisms in adipocyte models, with particular focus on beta-3 adrenergic receptor engagement and inhibition of lipogenesis pathways. Animal studies involving diet-induced obesity models provided early mechanistic data on its fat-mass-reducing effects at the cellular level. The compound's selective activity profile — distinct from full hGH — has made it a useful tool for dissecting the specific domains of hGH responsible for individual metabolic actions in comparative peptide biology research. All outcomes referenced pertain to preclinical models and do not constitute evidence of clinical efficacy or safety in humans.
Specifications
| Compound | AOD-9604 |
| Format | Lyophilized Powder |
| Size | 10mg |
| Purity (HPLC) | ≥99% |
| Item # | BME-AOD960-A |
| Storage | −20°C, dry, dark |
| Price (CAD) | $75.99 |
COA / Testing
Batch documentation and third-party testing information are available for batch BME-AOD960-A. COA previews appear only when documentation exists for the active batch.
Storage & Handling
Store lyophilised AOD9604 at −20°C in its original sealed vial, protected from light and moisture. Avoid repeated freeze-thaw cycles, which degrade peptide structure and compromise assay reproducibility. Reconstituted solutions should be aliquoted into single-use volumes and stored at −80°C; refer to the lot-specific COA for validated stability parameters.
Shipping & Returns
Orders are processed on business days. Packaging is selected to maintain compound integrity in transit. Shipping timelines and return conditions are outlined in full in the Shipping & Returns policy — review before checkout if you have specific requirements. For orders with time-sensitive research schedules, contact support before placing your order.
Research Use Disclaimer
This product is supplied strictly for in-vitro and laboratory research use. It is not a drug, food supplement, or cosmetic and is not approved for human or veterinary clinical applications, diagnostics, or therapeutic use. Researchers are responsible for compliance with all applicable institutional and regulatory requirements in their jurisdiction.
Preparation Reference Guide
Research Solution Reference Calculator
Pre-filled with 10mg. Enter your solvent volume and target amount to see concentration and units on a U-100 syringe scale.
Concentration—
Volume to draw—
Syringe units (U-100)—
Per insulin unit—
For research-use calculations only. Always verify measurements independently — not medical guidance.
Questions before you order?
Browse the FAQ for documentation, storage, and sourcing answers, or contact our support team directly. We aim to respond to all research procurement inquiries within one business day.
Related
